Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

McMaster University

$17,500.00

Frailty as a Consideration for Chemotherapy and Anesthetic Regimens in Older Gynecologic Oncology Patients: A Multicentered Factorial Trial

FY 2021-22

Summary
Background: As surgical populations become increasingly aged and comorbid, frailty can be used to amalgamate the impact of age-related and disease-related states of vulnerability. Frailty and management decisions regarding surgery and chemotherapy, sequence, and regimens are found to alter short and long-term outcomes in this patient population. Despite this knowledge, optimal management strategies are not clearly defined.Objective: This study will evaluate the effects of alternative chemotherapy and anesthetic regimens, in older Gynecologic Oncology (GO) adults classified as frail, on all cause death or new disability at 6 months after surgery. Disability will be measured using the 12-item World Health Organization Disability Assessment Scheduele.Methods: This is a multicentered factorial trial of frail GO adults aged 55 years or older who are candidates for surgery and chemotherapy. Eligibility for frailty will be determined using the Clinical Frailty Scale. Patients will be randomized to 2 separate interventions and blinded to their treatment allocation. The first intervention includes a lower dose of carboplatin plus paclitaxel every 3 weeks compared to standard care. The second intervention aims to minimize sedation and optimize regional and nonnarcotic anesthetics following surgery. Statistical analysis will be conducted to report differences between groups and possible synergistic effects of the 2 interventions.Significance: This study will be the first of its kind to evaluate treatment outcomes in older GO surgical patients. It will fill existing gaps in surgical oncology research relating to frailty which largely consists of retrospective studies. Moroever, it will define outcomes for frail patients who are often underrepresented in oncology research.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
466888
Name
Sabac Denise A
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Frailty as a Consideration for Chemotherapy and Anesthetic Regimens in Older Gynecologic Oncology Patients: A Multicentered Factorial Trial
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Anesthesia; Chemotherapy; Frailty; Gynecologic Oncology; Neurocognition; Older Adults
Abstract
Background: As surgical populations become increasingly aged and comorbid, frailty can be used to amalgamate the impact of age-related and disease-related states of vulnerability. Frailty and management decisions regarding surgery and chemotherapy, sequence, and regimens are found to alter short and long-term outcomes in this patient population. Despite this knowledge, optimal management strategies are not clearly defined.Objective: This study will evaluate the effects of alternative chemotherapy and anesthetic regimens, in older Gynecologic Oncology (GO) adults classified as frail, on all cause death or new disability at 6 months after surgery. Disability will be measured using the 12-item World Health Organization Disability Assessment Scheduele.Methods: This is a multicentered factorial trial of frail GO adults aged 55 years or older who are candidates for surgery and chemotherapy. Eligibility for frailty will be determined using the Clinical Frailty Scale. Patients will be randomized to 2 separate interventions and blinded to their treatment allocation. The first intervention includes a lower dose of carboplatin plus paclitaxel every 3 weeks compared to standard care. The second intervention aims to minimize sedation and optimize regional and nonnarcotic anesthetics following surgery. Statistical analysis will be conducted to report differences between groups and possible synergistic effects of the 2 interventions.Significance: This study will be the first of its kind to evaluate treatment outcomes in older GO surgical patients. It will fill existing gaps in surgical oncology research relating to frailty which largely consists of retrospective studies. Moroever, it will define outcomes for frail patients who are often underrepresented in oncology research.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Sabac, Denise A
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~